Skip to content

TLX TELIX PHARMACEUTICAL LTD

Follow

ADR (ADR), issuer CIK 2007191

7 managers (7 13F filers) reported a position in TLX shares at 2025-03-31, 47,647 shares in all. 5 filers opened a position and 0 filers sold out during the quarter.

Managers
7
13F filers
7
New
5
Added
0
Reduced
1
Sold out
0
Shares held by filers
47,647

Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.

13D and 13G filers

No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.

Insider trades

No Form 4 transaction on this security in the data.

13F holders, Q1 2025

Filers in the available 13F reports with a share position at 2025-03-31, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.

HolderSharesValue% of portfolioChangeSource
ABC ARBITRAGE SAin group ABC ARBITRAGE SA26,939$451K0.08%new13F-HRTimelineGroup
Private Advisor Group, LLC10,140$170K<0.01%new13F-HRTimeline
MORGAN STANLEYin group MORGAN STANLEY5,634$94.4K<0.01%new13F-HRTimelineGroup
UBS Group AGin group UBS Group AG3,651$61.2K<0.01%-7913F-HRTimelineGroup
RHUMBLINE ADVISERS1,146$19.2K<0.01%new13F-HR/ATimeline
EverSource Wealth Advisors, LLCin group EverSource Wealth Advisors, L…137$2.3K<0.01%new13F-HRTimelineGroup
CONCOURSE FINANCIAL GROUP SECURITIES, I…0$0013F-HRTimelineValue filed as zero, left out of ratios. Amount filed as zero, left out of ratios.